The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures. Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project … We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission. Surveillance Population frequency of gene variants predisposing to specific diseases Population frequency of morbidity and mortality from such diseases Population frequency and effects of environmental factors known to interact with gene variants Economic costs of genetic components of diseases Coverage, access, and uptake of genetic tests and services Aetiology Magnitude of disease risk associated with gene variants in different populations Contribution of gene variants to the overall level of disease in different populations Magnitude of disease risk associated with gene–gene and gene–environment interactions in different populations Heal
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The essence of an MR design is that the association between a genetic variant (G) and an outcome (Y) can be used to test whether and by how much the exposure of interest (X) influences the outcome, provided that the genetic variant is associated with the exposure of interest and has no other source of association with the outcome.1,9”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“When initially presented, it was concluded that “[MR] offers a more robust approach to understanding the effect of some modifiable exposures on health outcomes than does much conventional observational epidemiology”1 and that where possible, RCTs should follow to establish the effects of interventions. This conclusion remains unchanged, although moving towards formal triangulation of all pertinent”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Canalization can occur when polymorphic phenotypes expressed during fetal development lead to the development of compensating pathways to mitigate the effects of that expression. 1,178,179”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Estimating effect sizes through the instrumental variable approach imposes a fourth assumption, usually homogeneity of effects of the exposure on the outcome.16 58 59 60”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Most MR studies rely on three core IV assumptions (relevance, independence, and exclusion restriction; fig 1, box 3) to carry out testing for causal effects of the exposure on the outcome.16”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Similarly, violation of the ‘exclusion restriction criteria’33–37 could bias causal estimates in IV analyses when used to test effects of intermediates in RCTs or when used in observational data (including MR)”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“but may be confounded by population stratification.33,34”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“Human genetics can provide compelling evidence of causation through approaches such as Mendelian randomization (MR).”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Performed well, such studies called Mendelian randomization (MR) analyses, can provide rigorous evidence of causation 9,10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“We can exploit the properties of the human genome (specifically, the random segregation of alleles and their non-modifiable nature) to make causal inferences about the relationships between risk factors and disease 10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Mendelian randomization uses genetic variants, assumed to be instrumental variables for a particular exposure, to estimate the causal effect of that exposure on an outcome.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
In the citing paper
“If the instrumental variable criteria are satisfied, the resulting estimator is consistent even in the presence of unmeasured confounding and reverse causation.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,679
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255
Research works printed but not linked: 3
- Skrabanek P. False Premises, False Promises. Whithorn: Tarragon Press, 2000.
- http://www.ncbi.nlm.nih.gov/Omim (accessed 12 Dec 2002).
- Heart Protection Study Collaborative Group. MRC/BHF heart protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. Lancet2002;360:7–22. · DOI · Paper page
Cited by
Sorted by citations
Items 901–1,000 of 1,037
Association between Sleep Traits and Lung Cancer: A Mendelian Randomization Study
Wang, J., Tang, H., Duan, Y., Yang, S., & An, J. (2021) · Journal of Immunology Research · doi:10.1155/2021/1893882 · Cited by 61
Gao, N., Kong, M., Li, X., Zhu, X., Wei, D., Ni, M., Wang, Y., Hong, Z., & Dong, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918224 · Cited by 65
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study
Nounu, A., Kar, S., Relton, C. L., & Richmond, R. C. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01553-9 · Cited by 64
Mendelian Randomization: A New Approach to Studying Epidemiology in ESRD
Zoccali, C., Testa, A., Spoto, B., Tripepi, G. L., & Mallamaci, F. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.027 · Cited by 63
Mendelian randomization study of height and risk of colorectal cancer
Thrift, A. P., Gong, J., Peters, U., Chang-Claude, J. C., Rudolph, A., Slattery, M. L., Chan, A. T., Esko, T., Wood, A. R., Yang, J., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv082 · Cited by 61
Genetic evidence for assortative mating on alcohol consumption in the UK Biobank
Howe, L. J., Lawson, D. J., Davies, N. M., St. Pourcain, B., Lewis, S. J., Davey Smith, G., & Hemani, G. (2019) · Nature Communications · doi:10.1038/s41467-019-12424-x · Cited by 63
Garfield, V. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16224327 · Cited by 69
Seow, A., Vainio, H., & Yu, M. C. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.06.004 · Cited by 63
Folate supplementation and cardiovascular disease
Smith, G. D., & Ebrahim, S. B. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67676-3 · Cited by 63
Self-citationBurgess, S., Bowden, J., Dudbridge, F., & Thompson, S. G. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1606.03729 · Cited by 77
Neeland, I. J., & Kozlitina, J. (2017) · Circulation · doi:10.1161/circulationaha.117.026857 · Cited by 62
Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study
Fussey, J. M., Beaumont, R. N., Wood, A. R., Vaidya, B., Smith, J. A., & Tyrrell, J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa250 · Cited by 65
Fibrinogen Studies Collaboration (2009) · Statistics in Medicine · doi:10.1002/sim.3530 · Cited by 63
Testa, A., Mallamaci, F., Benedetto, F. A., Pisano, A., Tripepi, G. L., Malatino, L., Thadhani, R., & Zoccali, C. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090717 · Cited by 62
Lewis, S. J., Araya, R., Leary, S. D., Smith, G. D., & Ness, A. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.136 · Cited by 62
Herder, C., Illig, T., Baumert, J., Müller‐Nurasyid, M., Klopp, N., Khuseyinova, N., Meisinger, C., Martin, S., Thorand, B., & Köenig, W. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.025 · Cited by 62
Katikireddi, S. V., Green, M. J., Taylor, A. E., Smith, G. D., & Munafo, M. R. (2017) · Addiction · doi:10.1111/add.14038 · Cited by 63
Psychosocial factors and public health
Singh‐Manoux, A. (2003) · Journal of Epidemiology & Community Health · doi:10.1136/jech.57.8.553 · Cited by 62
Keavney, B. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh275 · Cited by 62
Efstathiadou, A., Gill, D., McGrane, F., Quinn, T. J., & Dawson, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012738 · Cited by 63
Millard, L. A. C., Munafo, M. R., Tilling, K. M., Wootton, R. E., & Smith, G. D. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008353 · Cited by 61
Richardson, T. G., Wang, Q., Sanderson, E. C. M., Mahajan, A., McCarthy, M. I., Frayling, T. M., Ala‐Korpela, M., Sniderman, A. D., Smith, G. D., & Holmes, M. V. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00086-6 · Cited by 61
Genetic risk factors have a substantial impact on healthy life years
Jukarainen, S., Kiiskinen, T., Kuitunen, S., Havulinna, A. S., Karjalainen, J. M., Cordioli, M., Rämö, J. T., Mars, N., FinnGen, Samocha, K. E., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01957-2 · Cited by 68
Gaziano, L., Sun, L., Arnold, M., Bell, S., Cho, K., Kaptoge, S. K., Song, R. J., Burgess, S., Posner, D. C., Mosconi, K., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.060700 · Cited by 65
Skaaby, T., Husemoen, L. L. N., Martinussen, T., Thyssen, J. P., Melgaard, M., Thuesen, B. H., Pisinger, C. H., Jørgensen, T., Johansen, J. D., Menné, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057647 · Cited by 60
Cognitive and Behavioral Profiles of Children with Fetal Alcohol Spectrum Disorders
Kodituwakku, P. W., & Kodituwakku, E. L. (2014) · Current Developmental Disorders Reports · doi:10.1007/s40474-014-0022-6 · Cited by 61
Lawlor, D., Fraser, A., Ebrahim, S., & Smith, G. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040263 · Cited by 74
Self-citationMika Kivimaki, B., Magnussen, C. G., Juonala, M., Kähönen, M. A. P., Kettunen, J., Loo, B.-M., Lehtimäki, T. J., Viikari, J. S. A., & Raitakari, O. T. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq205 · Cited by 61
Wium‐Andersen, M. K., Ørsted, D. D., & Nordestgaard, B. G. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150870 · Cited by 60
Ueshima, H., Kadowaki, T., Hisamatsu, T., Fujiyoshi, A., Miura, K., Ohkubo, T., Sekikawa, A. M., Kadota, A., Kadowaki, S., Nakamura, Y., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.027 · Cited by 61
Moayyeri, A., Cheung, C., Tan, K. C. B., Morris, J. A., Cerani, A., Mohney, R. P., Richards, J. B., Hammond, C. J., Spector, T. D., & Menni, C. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3358 · Cited by 61
Vitamin D and risk of pregnancy related hypertensive disorders: mendelian randomisation study
Magnus, M. C., Miliku, K., Bauer, A. E., Engel, S. M., Felix, J. F., Jaddoe, V. W. V., Lawlor, D. A., London, S. J., Magnus, P. M., McGinnis, R. E., et al. (2018) · BMJ · doi:10.1136/bmj.k2167 · Cited by 60
EpiGraphDB: a database and data mining platform for health data science
Liu, Y., Elsworth, B., Erola, P., Haberland, V., Hemani, G., Lyon, M., Zheng, J., Lloyd, O. C., Vabistsevits, M., & Gaunt, T. R. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa961 · Cited by 60
Body mass index and colorectal cancer risk: A Mendelian randomization study
Suzuki, S., Goto, A., Nakatochi, M., Narita, A., Yamaji, T., Sawada, N., Katagiri, R., Iwagami, M., Hanyuda, A., Hachiya, T., et al. (2021) · Cancer Science · doi:10.1111/cas.14824 · Cited by 60
Pistis, G., Milaneschi, Y., Vandeleur, C. L., Lasserre, A. M., Penninx, B. W. J. H., Lamers, F., Boomsma, D. I., Hottenga, J., Marques-Vidal, P. M., Vollenweider, P., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01236-7 · Cited by 58
Where the genome meets the connectome: Understanding how genes shape human brain connectivity
Arnatkevičiūtė, A., Fulcher, B., Bellgrove, M. A., & Fornito, A. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118570 · Cited by 60
Chen, F., Wen, W., Long, J., Shu, X., Yang, Y., Shu, X., & Zheng, W. (2022) · International Journal of Cancer · doi:10.1002/ijc.34026 · Cited by 61
Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies
Lawler, T., & Andersen, S. W. (2023) · Nutrients · doi:10.3390/nu15020422 · Cited by 60
Power, G. M., Sanderson, E. C. M., Pagoni, P., Fraser, A., Morris, T., Prince, C., Frayling, T. M., Heron, J., Richardson, T. G., Richmond, R. C., et al. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-01032-1 · Cited by 61
Groom, A., Potter, C., Swan, D., Fatemifar, G., Evans, D. M., Ring, S. M., Turcot, V., Pearce, M. S., Embleton, N. D., Smith, G. D., et al. (2011) · Diabetes · doi:10.2337/db11-1039 · Cited by 61
Bayesian Meta-Analysis of Genetic Association Studies with Different Sets of Markers
Verzilli, C. J., Shah, T., Casas, J. P., Chapman, J. M., Sandhu, M. S., Debenham, S. L., Boekholdt, S. M., Khaw, K., Wareham, N. J., Judson, R., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.016 · Cited by 58
Capitalizing on Mendelian randomization to assess the effects of treatments
Smith, G. D. (2007) · Journal of the Royal Society of Medicine · doi:10.1177/014107680710000923 · Cited by 60
Apolipoprotein E Genotype, Plasma Cholesterol, and Cancer: A Mendelian Randomization Study
Trompet, S., Jukema, J. W., Katan, M., Blauw, G. J., Sattar, N. A., Buckley, B. M., CASLAKE, M. J., Ford, I., Shepherd, J., Westendorp, R. G. J., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp294 · Cited by 60
Association Between C-Reactive Protein Genotype, Circulating Levels, and Aortic Pulse Wave Velocity
Schumacher, W., Cockcroft, J., Timpson, N. J., McEniery, C. M., Gallacher, J., Rumley, A., Lowe, G. D. O., Smith, G. D., Wilkinson, I. B., & Ben‐Shlomo, Y. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.117622 · Cited by 61
Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective
Nimptsch, K., & Pischon, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_11 · Cited by 62
Ahmad, O. S., Leong, A., Miller, J. A., Morris, J. A., Forgetta, V., Mujammami, M. H., & Richards, J. B. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3063 · Cited by 62
Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis
Wang, N., Chen, C., Zhao, L., Chen, Y., Han, B., Xia, F., Cheng, J., Li, Q., & Lu, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.027 · Cited by 61
on behalf of the China Kadoorie Biobank Collaborative Group, Huang, T., Afzal, S., Yu, C., Guo, Y., Bian, Z., Yang, L., Millwood, I. Y., Walters, R. G., Chen, Y., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1401-y · Cited by 60
Jiang, X., Ge, T., & Chen, C. (2021) · Scientific Reports · doi:10.1038/s41598-020-80655-w · Cited by 60
Self-regulation and control in personality functioning
Carver, C. S., & Scheier, M. F. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.027 · Cited by 59
Insight into rheumatological cause and effect through the use of Mendelian randomization
Robinson, P. C., Choi, H. K., Do, R., & Merriman, T. R. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.102 · Cited by 59
Strengthening Causal Inference for Complex Disease Using Molecular Quantitative Trait Loci
Neumeyer, S., Hemani, G., & Zeggini, E. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.004 · Cited by 55
Understanding the Interplay Between Health Disparities and Epigenomics
Mancilla, V. J., Peeri, N. C., Silzer, T. K., Basha, R. M., Felini, M., Jones, H. P., Phillips, N., Tao, M., Thyagarajan, S., & Vishwanatha, J. K. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00903 · Cited by 63
Dong, S., Zhang, K., Guo, Y., Ding, J., Feng, J.-C., Yao, S., Yao, S., Rong, Y., Jiang, F., Chen, J., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00865-3 · Cited by 58
Lu, Y., Tang, H., Huang, P., Wang, J., Deng, P., Li, Y., Zheng, J., & Weng, L. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac025 · Cited by 58
Asthma and the risk of gastrointestinal disorders: a Mendelian randomization study
Freuer, D., Linseisen, J., & Meisinger, C. (2022) · BMC Medicine · doi:10.1186/s12916-022-02283-7 · Cited by 61
Hamilton, F., Hughes, D. A., Spiller, W., Tilling, K. M., & Smith, G. D. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01113-9 · Cited by 61
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Kentistou, K. A., Kaisinger, L. R., Stankovic, S., Vaudel, M., de Oliveira, E. M., Messina, A., Walters, R. G., Liu, X., Busch, A. S., Helgason, H., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01798-4 · Cited by 81
Lawlor, D. A., Smith, G. D., & Ebrahim, S. B. J. (2004) · American Journal of Public Health · doi:10.2105/ajph.94.12.2149 · Cited by 59
Self-citationHigh body mass index and cancer risk—a Mendelian randomisation study
Benn, M., Tybjærg‐Hansen, A., Smith, G. D., & Nordestgaard, B. G. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0147-5 · Cited by 59
Mendelian randomization to assess causal effects of blood lipids on coronary heart disease
Burgess, S., & Harshfield, E. L. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000230 · Cited by 58
Kuźma, E., Hannon, E. J., Zhou, A., Lourida, I., Bethel, A. C., Levine, D. A., Lunnon, K., Coon, J. T., Hyppönen, E., & Llewellyn, D. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180013 · Cited by 63
Richardson, T. G., Haycock, P., Zheng, J., Timpson, N. J., Gaunt, T. R., Smith, G. D., Relton, C. L., & Hemani, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy210 · Cited by 57
Adult height in relation to risk of cancer in a cohort of 22,809,722 Korean adults
Choi, Y. J., Lee, D. H., Han, K., Yoon, H., Shin, C. M., Park, Y. S., & Kim, N. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0371-8 · Cited by 59
Anderson, E. L., Richmond, R. C., Jones, S. E., Hemani, G., Wade, K. H., Dashti, H. S., Lane, J. M., Wang, H., Saxena, R., Brumpton, B. M., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa183 · Cited by 57
Kunutsor, S. K., Kurl, S., Zaccardi, F., & Laukkanen, J. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.020 · Cited by 58
Jamieson, E., Korologou‐Linden, R., Wootton, R. E., Guyatt, A. L., Battram, T., Burrows, K., Gaunt, T. R., Tobin, M. D., Munafo, M. R., Smith, G. D., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.01.015 · Cited by 59
Stroke Genetics: Discovery, Insight Into Mechanisms, and Clinical Perspectives
Debette, S., & Markus, H. S. (2022) · Circulation Research · doi:10.1161/circresaha.122.319950 · Cited by 64
Association Between Myopic Refractive Error and Primary Open-Angle Glaucoma
Choquet, H., Khawaja, A. P., Jiang, C., Yin, J., Melles, R. B., Glymour, M. M., Hysi, P. G., & Jorgenson, E. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.2762 · Cited by 58
Yang, Q., Borges, M. C., Sanderson, E. C. M., Magnus, M. C., Kilpi, F., Collings, P. J., Soares, A. G., West, J., Magnus, P. M., Wright, J., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004090 · Cited by 58
Liu, B., Lyu, L., Zhou, W., Song, J., Ye, D., Mao, Y., Chen, G., & Sun, X. (2023) · BMC Medicine · doi:10.1186/s12916-023-02736-7 · Cited by 59
Wu, X., Zhang, W., Zhao, X., Zhang, L., Xu, M., Hao, Y., Xiao, J., Zhang, B., Li, J., Kraft, P. L., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02876-w · Cited by 62
Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases
Meng, Q., Mäkinen, V., Luk, H., & Yang, X. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0280-y · Cited by 58
Caramaschi, D., Sharp, G. C., Nohr, E. A., Berryman, K., Lewis, S. J., Smith, G. D., & Relton, C. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx164 · Cited by 61
Sanderson, E. C. M., Smith, G. D., Bowden, J., & Munafo, M. R. (2019) · Nature Communications · doi:10.1038/s41467-019-10679-y · Cited by 55
Harrison, R., Munafo, M. R., Smith, G. D., & Wootton, R. E. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.68 · Cited by 60
Mendelian Randomization: Application to Cardiovascular Disease
Timpson, N. J., Wade, K. H., & Smith, G. D. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0242-7 · Cited by 60
Cao, Y., Su, N., Zhang, D., Zhou, L., Yao, M., Zhang, S., Cui, L., Zhu, Y., & Ni, J. (2020) · European Journal of Neurology · doi:10.1111/ene.14708 · Cited by 57
Brown, A. W., Aslibekyan, S. W., Bier, D. M., da Silva, R. F., Hoover, A. W., Klurfeld, D. M., Loken, E., Mayo‐Wilson, E., Menachemi, N., Pavela, G., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1985427 · Cited by 63
Yin, Z., Liu, B., Feng, S., He, Y., Tang, C., Chen, P., Wang, X., & Wang, K. (2023) · Nutrients · doi:10.3390/nu15184086 · Cited by 61
CRP CHD Genetics Collaboration (2008) · European Journal of Epidemiology · doi:10.1007/s10654-008-9249-z · Cited by 56
Nutritional epidemiology—past, present, future
Michels, K. B. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg216 · Cited by 61
Rassen, J. A., Mittleman, M. A., Glynn, R. J., Brookhart, M. A., & Schneeweiß, S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp437 · Cited by 57
Panoulas, V. F., Douglas, K., Smith, J., Taffé, P., Stavropoulos‐Kalinoglou, A., Toms, T. E., Elisaf, M., Nightingale, P., & Kitas, G. D. (2008) · Endothelium · doi:10.1080/10623320802228708 · Cited by 57
Genetics and public health—evolution, or revolution?
Halliday, J. L., Collins, V. R., Aitken, M. A., Richards, M. P. M., & Olsson, C. A. (2004) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2003.018515 · Cited by 57
Kemp, J. P., Sayers, A. E., Smith, G. D., Tobias, J. H., & Evans, D. M. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw079 · Cited by 58
Yuan, S., Lin, A., He, Q., Burgess, S., & Larsson, S. C. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.053 · Cited by 57
Mills, H. L., Higgins, J. P. T., Morris, R. W., Kessler, D. S., Heron, J., Wiles, N., Smith, G. D., & Tilling, K. M. (2021) · Epidemiology · doi:10.1097/ede.0000000000001401 · Cited by 59
Interpretation of mendelian randomization using one measure of an exposure that varies over time
Morris, T. T., Heron, J., Sanderson, E., Smith, G. D., & Tilling, K. (2021) · doi:10.1101/2021.11.18.21266515 · Cited by 58
Plasma Urate, Cancer Incidence, and All-Cause Mortality: A Mendelian Randomization Study
Kobylecki, C. J., Afzal, S., & Nordestgaard, B. G. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.268185 · Cited by 56
Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation
Obeidat, M., Li, X., Burgess, S., Zhou, G., Fishbane, N., Hansel, N. N., Bossé, Y., Joubert, P., Hao, K., Nickle, D. C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00657-2017 · Cited by 55
Causal effects of inflammatory protein biomarkers on inflammatory diseases
Ek, W. E., Karlsson, T., Höglund, J., Rask‐Andersen, M., & Johansson, Å. (2021) · Science Advances · doi:10.1126/sciadv.abl4359 · Cited by 55
Mendelian randomization in pharmacogenomics: The unforeseen potentials
Khasawneh, L. Q., Al-Mahayri, Z. N., & Ali, B. R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112952 · Cited by 54
Li, Y., Guo, J., Cao, Z., & Wu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.916645 · Cited by 56
Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases
Chen, C., Wang, P., Zhang, R.-D., Yang, F., Jiang, L.-Q., Fang, X., Zhao, Y., Wang, D., Ni, J., & Pan, H. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103210 · Cited by 56
Lack of causal association between heart failure and osteoporosis: a Mendelian randomization study
Chen, H., Ye, R., & Guo, X. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01385-8 · Cited by 56
Karageorgiou, V., Casanova, F., O’Loughlin, J., Green, H., McKinley, T. J., Bowden, J., & Tyrrell, J. (2023) · BMC Medicine · doi:10.1186/s12916-023-03001-7 · Cited by 60
Burgess, S., & Cronjé, H. T. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100042 · Cited by 57
Ma, J., Li, P., Li, P., Yang, X., Zhu, S., 马科, Gao, F., Gao, H., Zhang, H., Ma, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46973-7 · Cited by 56
Impact of Cortisol on Reduction in Muscle Strength and Mass: A Mendelian Randomization Study
Katsuhara, S., Yokomoto-Umakoshi, M., Umakoshi, H., Matsuda, Y., Iwahashi, N., Kaneko, H., Ogata, M., Fukumoto, T., Terada, E., Sakamoto, R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab862 · Cited by 55
Metadata
- Authors
- Davey Smith, G., & Ebrahim, S.
- ORCID
- Ebrahim, Shah
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02
- Volume
- 32
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2106036991
- Cited by
- 5,882
- References
- 179
- Citations by year
- 2026: 333 · 2025: 673 · 2024: 1162 · 2023: 681 · 2022: 453 · 2021: 442 · 2020: 353 · 2019: 235 · 2018: 201 · 2017: 157 · 2016: 163 · 2015: 118 · 2014: 115 · 2013: 94 · 2012: 101
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- Mendelian randomization, genetic epidemiology, environmental factors in disease, causal inference, confounding, reverse causality, linkage disequilibrium, canalization, genetic polymorphism, genetic testing, public health genetics, disease prevention, Human Genome Project, pathogenesis, cancer genetics
- MeSH terms
- Animals, Disease, Environmental Exposure, Genotype, Humans, Polymorphism, Genetic, Molecular Epidemiology, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
